Serena Cardillo, MD

faculty photo
Associate Professor of Clinical Medicine
Department: Medicine

Contact information
University of Pennsylvania Perelman School of Medicine
Division of Endocrinology, Diabetes and Metabolism
Perelman Center for Advanced Medicine, West Pavilion, 4th Floor
3400 Civic Center Blvd.
Philadelphia, PA 19104
Office: 215-662-2468
B.A. (Behavioral Biology)
Johns Hopkins University, 1997.
University of Pennsylvania Perelman School of Medicine, 2001.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

Dr. Cardillo joined the faculty in the Division of Endocrinology, Diabetes, & Metabolism as an Assistant Professor of Medicine in 2006. She completed her undergraduate studies at Johns Hopkins University where she received a B.A. in Behavioral Biology. She received her M.D. from the University of Pennsylvania and completed both a residency in Internal Medicine and a fellowship in Endocrinology at the Hospital of the University of Pennsylvania. Her clinical interests include diabetes management, transplant associated diabetes, pre-diabetes and metabolic syndrome and diabetes in bariatric surgery patients. Her clinical practice is based at the Penn Rodebaugh Diabetes Center.

Description of Other Expertise

Dr. Cardillo is also actively involved in medical education at the residency and fellowship levels. She is currently the Director of Ambulatory Training for the Internal Medicine Residency Program and the Director of Graduate Diabetes Education.

Selected Publications

Rahul Agarwal MD and Serena Cardillo MD: Successful Long-Term Treatment of Hyperinsulinemic Hypoglycemia Using a Monthly Somatostatin Receptor Analog in a 91 Year Old Patient Poster Presentation, Endocrine Society March 2018.

Leonard CE, Han X, Brensinger CM, Bilker WB, Cardillo S, Flory JH, Hennessy S.: Comparative risk of serious hypoglycemia with oral antidiabetic monotherapy: A retrospective cohort study. Pharmacoepidemiol Drug Saf. 27(1): 9-18, January 2018.

Lo Re V, Carbonari DM, Saine ME, Newcomb CW, Roy JA, Liu Q, Wu Q, Cardillo S, Haynes K, Kimmel SE, Reese PP, Margolis DJ, Apter AJ, Reddy KR, Hennessy S, Bhullar H, Gallagher AM, Esposito DB, Strom BL.: Postauthorization safety study of the DPP-4 inhibitor saxagliptin: a large-scale multinational family of cohort studies of five outcomes BMJ Open Diabetes Research and Care 5(1), July 2017.

Agarwal S, Raymond JK, Schutta MH, Cardillo S, Miller VA, Long JA: An Adult Health Care-Based Pediatric to Adult Transition Pogram for Emerging Adults with Type 1 Diabetes. Diabetes Educ 43(1): 87-96, February 2017.

Lum KJ, Newcomb CW, Roy JA, Carbonari DM, Saine ME, Cardillo S, Bhullar H, Gallagher AM, Lo Re V 3rd: Evaluation of methods to estimate missing days' supply within pharmacy data of the Clinical Practice Research Datalink (CPRD) and The Health Improvement Network (THIN). Eur J Clin Pharmacol 73(1): 115-123, January 2017.

Charles E Leonard, Xu Han, Warren B Bilker, James H Flory, Colleen M Bresinger, David A Flockhart, Joshua J Gagne, Serena Cardillo, Sean Hennessy: Comparative risk of severe hypoglycemia among concomitant users of thiazolidinedione antidiabetic agents and antihyperlipidemics. Diabetes Res. Clin. Pract. 115: 60-7, May 2016 Notes: doi: 10.1016/j.diabres.2016.03.006

Acton EK, Leonard CE, Schutta MH, Cardillo S, Troxel AB, Trotta R, Hennessy S. : Challenges in recruiting subjects to a pilot trial of patient-managed in-hospital insulin BMC Research Notes October 2015 Notes: 8:523. doi: 10.1186/s13104-015-1480-6.

Carbonari DM, Saine ME, Newcomb CW, Blak B, Roy JA, Haynes K, Wood J, Gallagher AM, Bhullar H, Cardillo S, Hennessy S, Strom BL, Lo Re V 3rd. : Use of demographic and pharmacy data to identify patients included within both the Clinical Practice Research Datalink (CPRD) and The Health Improvement Network (THIN) Pharmacoepidemiol Drug Safety 24(9): 999-1003, September 2015.

Saine ME, Carbonari DM, Newcomb CW, Nezamzadeh MS, Haynes K, Roy JA, Cardillo S, Hennessy S, Holick CN, Esposito DB, Gallagher AM, Bhullar H, Strom BL, Lo Re V 3rd. : Determinants of saxagliptin use among patients with type 2 diabetes mellitus treated with oral anti-diabetic drugs BMC Pharmacol Toxicol. 16(8), April 2015 Notes: doi: 10.1186/s40360-015-0007-z.

Kostic M, McCulloch DK, Young LA, Cardillo S, Hayes S, Lamarra D: Using simulation-based interprofessional interventions to improve communication skills of providers can enhance quality of care and patient outcomes in type 2 diabetes. ePoster. AAME 2015 Notes: Poster presentation.

back to top
Last updated: 06/18/2018
The Trustees of the University of Pennsylvania